Inflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature. Principles and Practice of Clinical Research, [S. l.], v. 9, n. 2, 2023. DOI: 10.21801/ppcrj.2023.92.7. Disponível em: https://journal.ppcr.org/index.php/ppcrjournal/article/view/265.. Acesso em: 21 may. 2024.